JANUVIA 50 MG TABLET BYDUREON 2 MG/0.65 ML JARDIANCE 10 MG TABLET SUBCUTANEOUS PEN INJECTOR JARDIANCE 25 MG TABLET BYDUREON BCISE 2 MG/0.

Similar documents
Y0133_StepTherapyCriteria _C 10/18/18 Y0133_StepTherapyCriteria _C es 10/18/18

ALBUTEROL - SCORE. Products Affected. Details. Step Therapy Criteria Optima Tier Gold Formulary Date Effective: November 1, 2018.

ALBUTEROL - SCORE. Products Affected. Details. Step Therapy Criteria Farm Bureau Health Plans Date Effective: November 1, 2018.

ALBUTEROL - SCORE. Products Affected. Details. Step Therapy Criteria Health Choice Generations 1 Tier Gold Effective Date: 11/01/2018.

ALPHA GLUCOSIDASE INHIBITOR THERAPY

ALBUTEROL - SCORE{XE "ALBUTEROL - SCORE"}

ADHD STIMULANTS - SCORE

ADHD STIMULANTS - SCORE

DPP4 INHIBITORS. Products Affected Step 2: Janumet 50 mg-1,000 mg tablet Janumet 50 mg-500 mg tablet Januvia 100 mg tablet Januvia 25 mg tablet

DPP4 INHIBITORS. Details. Step Therapy Criteria Health Alliance Plan 2019 Date Effective: 04/01/2019

ALBUTEROL - SCORE. Products Affected. Details. Step Therapy Criteria Golden State Medicare Health Plan, Golden (HMO) Last Updated: 09/01/2018

CRITERIA Trial of two generic formulary products from the following: atomoxetine or ADHD stimulant medication.

ANTIDEPRESSANTS. Details. dose pack Viibryd 10 mg tablet Viibryd 20 mg tablet Viibryd 40 mg tablet. Criteria

Step Therapy Requirements. Effective: 11/01/2018

ANTICONVULSANTS. Details

ANTICONVULSANTS. Details

Step Therapy Requirements. Effective: 05/01/2018

ANTICONVULSANTS. Details

Santa Clara Family Health Plan Cal MediConnect Formulary. List of Step Therapy Requirements Effective: 12/01/ E

ANTICONVULSANT STEP THERAPY

AMANTADINE ER. Products Affected Step 2: OSMOLEX ER 129 MG TABLET, EXTENDED RELEASE OSMOLEX ER 193 MG TABLET, Details

ALLERGIC CONJUNCTIVITIS AGENTS

FirstCarolinaCare Insurance Company. Step Therapy Requirements

AMANTADINE ER. Products Affected Step 2: OSMOLEX ER 129 MG TABLET, EXTENDED RELEASE OSMOLEX ER 193 MG TABLET, Details

ANGIOTENSIN RECEPTOR BLOCKERS STEP THERAPY

Step Therapy Requirements

ANTICONVULSANTS. Details

Mercy Care Plan. Acyclovir Ointment. Products Affected. acyclovir ointment 5 % external Details. Criteria. Requires use of oral Acyclovir

Step Therapy Requirements. Effective: 1/1/2019

VNSNY CHOICE FIDA Complete Step Therapy Requirements. Effective: 01/01/2017

Medicare Part D Drugs that Require Step Therapy Effective 12/01/2017

AMANTADINE ER. Products Affected Step 2: OSMOLEX ER 129 MG TABLET, EXTENDED RELEASE OSMOLEX ER 193 MG TABLET, Details

Step Therapy Criteria

ANTIDIABETIC AGENTS - MISCELLANEOUS

5-ASA. Products Affected DIPENTUM 250 MG CAPSULE LIALDA 1.2 GRAM TABLET,DELAYED RELEASE. Details

5-ASA. Products Affected. Details. Dipentum 250 mg capsule. Lialda 1.2 gram tablet,delayed release

ANTIDIABETIC AGENTS - MISCELLANEOUS

ANTIDIABETIC AGENTS - MISCELLANEOUS

Harvard Pilgrim Health Care Stride SM Basic Rx (HMO), Stride SM Value Rx (HMO) and Stride SM Value Rx Plus (HMO) Step Therapy Requirements

VNSNY CHOICE FIDA Complete Step Therapy Requirements. Effective: 04/01/2019

Step Therapy Requirements

ANTIEMETICS STEP. Step Therapy Requirements Effective April 1, 2019

ACYCLOVIR OINT (CCHP2017)

ACYCLOVIR OINT (CCHP2017)

2017 Step Therapy Criteria

2018 Step Therapy Criteria (List of Step Therapy Criteria)

Harvard Pilgrim Health Care Stride SM Basic Rx (HMO), Stride SM Value Rx (HMO), Stride SM Value Rx Plus (HMO) and Stride SM Gain Rx (HMO)

ACYCLOVIR OINT (CCHP2017)

Step Therapy Criteria 2019

ANTICONVULSANTS. Details. Step Therapy Criteria Date Effective: April 1, 2019

ANTICONVULSANT THERAPY

ALOGLIPTIN STEP. Step Therapy Requirements Effective April 1, 2018

ALOGLIPTIN STEP. Step Therapy Requirements Effective June 1, 2018

ACYCLOVIR OINT (CCHP2017)

Mercy Care ALBENDAZOLE. Products Affected. ALBENZA TABLET 200 MG ORAL Details. Criteria. Refer to PA Guideline for approval criteria

TEST ANTICONVULSANT THERAPY. Products Affected. Step 2: Network Health Insurance Corporation NetworkCares Step Therapy Criteria Last Updated 11/2018

ANTIDEPRESSANTS. Details. Step Therapy 2018 Last Updated: 8/21/2018

2018 Step Therapy Criteria (List of Step Therapy Criteria)

Drugs That Require Step Therapy (ST) Step Therapy Medications

Granite Alliance Insurance Company (PDP) 2018 Step Therapy Criteria Last Updated: 10/23/18

FirstCarolinaCare Insurance Company Step Therapy Requirements

Step Therapy Requirements. Effective: 12/01/2016

Step Therapy Requirements

2018 AlohaCare Advantage Plus Formulary (HMO SNP) Drugs with Step Therapy Requirements

2018 AlohaCare Advantage Plus Formulary (HMO SNP) Drugs with Step Therapy Requirements

Acyclovir Ointment. Aetna Better Health Pennsylvania. Products Affected. acyclovir ointment 5 % external Details. Criteria

THERAPEUTIC AREA NAME STRENGTH DOSAGE FORM

2018 AlohaCare Advantage Plus Formulary (HMO SNP) Drugs with Step Therapy Requirements

ABILIFY INJ. Products Affected Step 2: ABILIFY MAINTENA PREFILLED SYRINGE 300 MG INTRAMUSCULAR ABILIFY MAINTENA PREFILLED SYRINGE 400 MG INTRAMUSCULAR

Step Therapy Requirements. Effective: 03/01/2015

Quarterly pharmacy formulary change notice

Step therapy Premium. Utilization management updates - January 1, Here s how it works:

ALPHA BLOCKERS. Products Affected Step 1: Details. Step 2: Rapaflo 4 mg capsule Rapaflo 8 mg capsule

ANTIDEPRESSANTS. Details. Step Therapy 2017 Last Updated: 5/23/2017

2018 Step Therapy (ST) Criteria

VNSNY CHOICE FIDA Complete Step Therapy Requirements. Effective: 01/01/2017

BYSTOLIC. Products Affected Step 2: BYSTOLIC 10 MG TABLET BYSTOLIC 2.5 MG TABLET. Details BYSTOLIC 20 MG TABLET BYSTOLIC 5 MG TABLET

ALOGLIPTIN STEP. Details. Step Therapy Requirements Effective November 1, 2017

Step Therapy Group. Atypical Antipsychotic Agents

2017 Step Therapy (ST) Criteria

Contents ALPHA BLOCKERS... 3 COLCRYS-PST... 4 DPP-4 INHIBITORS-PST... 5 HIGH RISK MEDICATIONS - SEDATIVE HYPNOTICS... 6

5-ASA. Products Affected Dipentum 250 mg capsule. Details. Lialda 1.2 gram tablet,delayed release

Formulary Medical Necessity Program

Quarterly pharmacy formulary change notice

Transcription:

ANTI DIABETICS BYDUREON 2 MG SUBCUTANEOUS JANUVIA 25 MG TABLET EXTENDED RELEASE SUSPENSION JANUVIA 50 MG TABLET BYDUREON 2 MG/0.65 ML JARDIANCE 10 MG TABLET SUBCUTANEOUS PEN INJECTOR JARDIANCE 25 MG TABLET BYDUREON BCISE 2 MG/0.85 ML JENTADUETO 2.5 MG-1,000 MG TAB SUBCUTANEOUS AUTO-INJECTOR JENTADUETO 2.5 MG-500 MG TAB BYETTA 10 MCG/DOSE(250 MCG/ML)2.4 JENTADUETO 2.5 MG-850 MG TAB ML SUBCUTANEOUS PEN JENTADUETO XR 2.5 MG-1,000 MG TAB BYETTA 5 MCG/DOSE (250 MCG/ML)1.2 ML JENTADUETO XR 5 MG-1,000 MG TAB SUBCUTANEOUS PEN SYNJARDY 12.5 MG-1,000 MG TAB INVOKAMET 150 MG-1,000 MG TAB SYNJARDY 12.5 MG-500 MG TAB INVOKAMET 150 MG-500 MG TABLET SYNJARDY 5 MG-1,000 MG TAB INVOKAMET 50 MG-1,000 MG TABLET SYNJARDY 5 MG-500 MG TAB INVOKAMET 50 MG-500 MG TABLET SYNJARDY XR 10 MG-1,000 MG TABLET, INVOKAMET XR 150 MG-1,000 MG TAB EXTENDED RELEASE INVOKAMET XR 150 MG-500 MG TAB SYNJARDY XR 12.5 MG-1,000 MG INVOKAMET XR 50 MG-1,000 MG TAB TABLET, EXTENDED RELEASE INVOKAMET XR 50 MG-500 MG TAB SYNJARDY XR 25 MG-1,000 MG TABLET, INVOKANA 100 MG TABLET EXTENDED RELEASE INVOKANA 300 MG TABLET SYNJARDY XR 5 MG-1,000 MG TABLET, JANUMET 50 MG-1,000 MG TABLET EXTENDED RELEASE JANUMET 50 MG-500 MG TABLET TRADJENTA 5 MG TABLET JANUMET XR 100 MG-1,000 MG TAB TRULICITY 0.75 MG/0.5 ML JANUMET XR 50 MG-1,000 MG TAB SUBCUTANEOUS PEN INJECTOR JANUMET XR 50 MG-500 MG TAB TRULICITY 1.5 MG/0.5 ML JANUVIA 100 MG TABLET SUBCUTANEOUS PEN INJECTOR Step 1: Trial of one generic formulary metformin or generic metformin combinations or sulfonylurea or thiazolidinedione. Janumet, Janumet XR, Januvia, Jentadueto, Jentadueto XR, Tradjenta, Formulary GLP1 agonist, Invokana, Invokamet, Invokamet XR, Jardiance, Synjardy. 1

ANTIDEPRESSANT THERAPY APLENZIN 174 MG TABLET,EXTENDED RELEASE APLENZIN 348 MG TABLET,EXTENDED RELEASE APLENZIN 522 MG TABLET,EXTENDED RELEASE DESVENLAFAXINE ER 100 MG TABLET,EXTENDED RELEASE 24 HR DESVENLAFAXINE ER 50 MG TABLET,EXTENDED RELEASE 24 HR DESVENLAFAXINE FUMARATE ER 100 MG TABLET, EXTENDED RELEASE 24 HR DESVENLAFAXINE FUMARATE ER 50 MG TABLET, EXTENDED RELEASE 24 HR EMSAM 12 MG/24 HR TRANSDERMAL 24 HOUR PATCH EMSAM 6 MG/24 HR TRANSDERMAL 24 HOUR PATCH EMSAM 9 MG/24 HR TRANSDERMAL 24 HOUR PATCH Step 1: Trial of TWO of the following formulary products: bupropion, mirtazapine, generic SSRI, or generic SNRI. Emsam or Aplenzin or Desvenlafaxine ER 50mg, 100mg 2

ATYPICAL ANTIPSYCHOTICS FANAPT 1 MG TABLET FANAPT 10 MG TABLET FANAPT 12 MG TABLET FANAPT 1MG(2)-2 MG(2)-4MG(2)-6 MG(2) TABLETS IN A DOSE PACK FANAPT 2 MG TABLET FANAPT 4 MG TABLET FANAPT 6 MG TABLET FANAPT 8 MG TABLET SAPHRIS 10 MG SUBLINGUAL TABLET SAPHRIS 2.5 MG SUBLINGUAL TABLET SAPHRIS 5 MG SUBLINGUAL TABLET Step 1: Trial of two oral, single-ingredient, generic formulary atypical antipsychotic agents. Fanapt or Saphris 3

FETZIMA THERAPY FETZIMA 120 MG CAPSULE,EXTENDED RELEASE FETZIMA 20 MG (2)-40 MG (26) CAPSULE,EXTENDED RELEASE,24 HR,DOSE PACK FETZIMA 20 MG CAPSULE,EXTENDED RELEASE FETZIMA 40 MG CAPSULE,EXTENDED RELEASE FETZIMA 80 MG CAPSULE,EXTENDED RELEASE Step 1: Generic venlafaxine immediate release tablets or extended release capsules. Fetzima 4

FILGRASTIM GRANIX 300 MCG/0.5 ML SUBCUTANEOUS SYRINGE GRANIX 300 MCG/ML SUBCUTANEOUS SOLUTION GRANIX 480 MCG/0.8 ML SUBCUTANEOUS SYRINGE GRANIX 480 MCG/1.6 ML SUBCUTANEOUS SOLUTION NEUPOGEN 300 MCG/0.5 ML INJECTION SYRINGE NEUPOGEN 300 MCG/ML INJECTION SOLUTION NEUPOGEN 480 MCG/0.8 ML INJECTION SYRINGE NEUPOGEN 480 MCG/1.6 ML INJECTION SOLUTION NIVESTYM 300 MCG/0.5 ML SUBCUTANEOUS SYRINGE NIVESTYM 480 MCG/0.8 ML SUBCUTANEOUS SYRINGE Step 1: Trial of Zarxio. Granix, Neupogen, or Nivestym 5

INVEGA TRINZA THERAPY INVEGA TRINZA 273 MG/0.875 ML INTRAMUSCULAR SYRINGE INVEGA TRINZA 410 MG/1.315 ML INTRAMUSCULAR SYRINGE INVEGA TRINZA 546 MG/1.75 ML INTRAMUSCULAR SYRINGE INVEGA TRINZA 819 MG/2.625 ML INTRAMUSCULAR SYRINGE Step 1: Invega Sustenna Invega Trinza 6

LEUKOTRIENE MODIFIER ASTHMA THERAPY zileuton er 600 mg tablet,extended release 12hr mphase ZYFLO 600 MG TABLET Step 1: Trial of generic formulary montelukast or generic zafirlukast. Step 2: Zyflo or Zileuton ER 7

NEUPRO THERAPY NEUPRO 1 MG/24 HOUR TRANSDERMAL 24 HOUR PATCH NEUPRO 2 MG/24 HOUR TRANSDERMAL 24 HOUR PATCH NEUPRO 3 MG/24 HOUR TRANSDERMAL 24 HOUR PATCH NEUPRO 4 MG/24 HOUR TRANSDERMAL 24 HOUR PATCH NEUPRO 6 MG/24 HOUR TRANSDERMAL 24 HOUR PATCH NEUPRO 8 MG/24 HOUR TRANSDERMAL 24 HOUR PATCH Step 1: Trial of one generic formulary dopamine agonist agent. Neupro. 8

OZEMPIC OZEMPIC 0.25 MG OR 0.5 MG (2 MG/1.5 ML) SUBCUTANEOUS PEN INJECTOR OZEMPIC 1 MG/DOSE (2 MG/1.5 ML) SUBCUTANEOUS PEN INJECTOR Step 1: Byetta or Bydureon AND Trulicity, Ozempic. 9

QTERN QTERN 10 MG-5 MG TABLET Step 1: Trial of Glyxambi. Qtern. 10

RHOFADE RHOFADE 1 % TOPICAL CREAM Step 1: Trial of Finacea and Mirvaso. Rhofade 11

RHOPRESSA RHOPRESSA 0.02 % EYE DROPS Step 1: Trial of any two formulary prostaglandin or prostamide analogs or dorzolamide, dorzolamide-timolol, betaxolol, Simbrinza, Alphagan P, Azopt, timolol maleate, brimonidine, carteolol, Cosopt, or levobunolol. Rhopressa. 12

RYTARY RYTARY 23.75 MG-95 MG CAPSULE,EXTENDED RELEASE RYTARY 36.25 MG-145 MG CAPSULE,EXTENDED RELEASE RYTARY 48.75 MG-195 MG CAPSULE,EXTENDED RELEASE RYTARY 61.25 MG-245 MG CAPSULE,EXTENDED RELEASE Step 1: Trial of any generic antiparkinson agent. Rytary 13

TOPICAL IMMUNOMODULATOR THERAPY ELIDEL 1 % TOPICAL CREAM pimecrolimus 1 % topical cream ST : Pending CMS Approval 14

TRELEGY TRELEGY ELLIPTA 100 MCG-62.5 MCG-25 MCG POWDER FOR INHALATION Step 1: Any two of the following: Advair, Breo, Symbicort, generic fluticasone-salmeterol combination. Trelegy 15

TRESIBA FLEXTOUCH THERAPY TRESIBA FLEXTOUCH U-100 INSULIN 100 UNIT/ML (3 ML) SUBCUTANEOUS PEN TRESIBA FLEXTOUCH U-200 INSULIN 200 UNIT/ML (3 ML) SUBCUTANEOUS PEN TRESIBA U-100 INSULIN 100 UNIT/ML SUBCUTANEOUS SOLUTION Step 1: Any one of the following: Lantus, Lantus Solostar, Toujeo, Toujeo Max. Tresiba Flextouch 16

UCERIS ORAL THERAPY budesonide dr-er 9 mg tablet,delayed and extended release Step 1: Both mesalamine 1200 mg delayed release and oral generic sulfasalazine. Uceris Tablet 17

ULORIC THERAPY ULORIC 40 MG TABLET ULORIC 80 MG TABLET Step 1: Trial of oral generic allopurinol. Uloric 18

VYZULTA VYZULTA 0.024 % EYE DROPS Step 1: Trial of any two formulary prostaglandin or prostamide analogs. Vyzulta. 19

INDEX A APLENZIN 174 MG TABLET,EXTENDED RELEASE... 2 APLENZIN 348 MG TABLET,EXTENDED RELEASE... 2 APLENZIN 522 MG TABLET,EXTENDED RELEASE... 2 B budesonide dr-er 9 mg tablet,delayed and extended release... 17 BYDUREON 2 MG SUBCUTANEOUS EXTENDED RELEASE SUSPENSION 1 BYDUREON 2 MG/0.65 ML SUBCUTANEOUS PEN INJECTOR... 1 BYDUREON BCISE 2 MG/0.85 ML SUBCUTANEOUS AUTO-INJECTOR 1 BYETTA 10 MCG/DOSE(250 MCG/ML)2.4 ML SUBCUTANEOUS PEN INJECTOR... 1 BYETTA 5 MCG/DOSE (250 MCG/ML)1.2 ML SUBCUTANEOUS PEN INJECTOR... 1 D DESVENLAFAXINE ER 100 MG TABLET,EXTENDED RELEASE 24 HR... 2 DESVENLAFAXINE ER 50 MG TABLET,EXTENDED RELEASE 24 HR... 2 DESVENLAFAXINE FUMARATE ER 100 MG TABLET, EXTENDED RELEASE 24 HR... 2 DESVENLAFAXINE FUMARATE ER 50 MG TABLET, EXTENDED RELEASE 24 HR... 2 E ELIDEL 1 % TOPICAL CREAM... 14 EMSAM 12 MG/24 HR TRANSDERMAL 24 HOUR PATCH... 2 EMSAM 6 MG/24 HR TRANSDERMAL 24 HOUR PATCH... 2 EMSAM 9 MG/24 HR TRANSDERMAL 24 HOUR PATCH... 2 F FANAPT 1 MG TABLET... 3 FANAPT 10 MG TABLET... 3 FANAPT 12 MG TABLET... 3 FANAPT 1MG(2)-2 MG(2)-4MG(2)-6 MG(2) TABLETS IN A DOSE PACK... 3 FANAPT 2 MG TABLET... 3 FANAPT 4 MG TABLET... 3 FANAPT 6 MG TABLET... 3 FANAPT 8 MG TABLET... 3 FETZIMA 120 MG CAPSULE,EXTENDED RELEASE... 4 FETZIMA 20 MG (2)-40 MG (26) CAPSULE,EXTENDED RELEASE,24 HR,DOSE PACK... 4 FETZIMA 20 MG CAPSULE,EXTENDED RELEASE... 4 FETZIMA 40 MG CAPSULE,EXTENDED RELEASE... 4 FETZIMA 80 MG CAPSULE,EXTENDED RELEASE... 4 G GRANIX 300 MCG/0.5 ML SUBCUTANEOUS SYRINGE... 5 GRANIX 300 MCG/ML SUBCUTANEOUS SOLUTION... 5 GRANIX 480 MCG/0.8 ML SUBCUTANEOUS SYRINGE... 5 GRANIX 480 MCG/1.6 ML SUBCUTANEOUS SOLUTION... 5 I INVEGA TRINZA 273 MG/0.875 ML INTRAMUSCULAR SYRINGE... 6 INVEGA TRINZA 410 MG/1.315 ML INTRAMUSCULAR SYRINGE... 6 INVEGA TRINZA 546 MG/1.75 ML INTRAMUSCULAR SYRINGE... 6 INVEGA TRINZA 819 MG/2.625 ML INTRAMUSCULAR SYRINGE... 6 INVOKAMET 150 MG-1,000 MG TABLET... 1 INVOKAMET 150 MG-500 MG TABLET 1 20

INVOKAMET 50 MG-1,000 MG TABLET... 1 INVOKAMET 50 MG-500 MG TABLET. 1 INVOKAMET XR 150 MG-1,000 MG TABLET, EXTENDED RELEASE... 1 INVOKAMET XR 150 MG-500 MG TABLET, EXTENDED RELEASE... 1 INVOKAMET XR 50 MG-1,000 MG TABLET, EXTENDED RELEASE... 1 INVOKAMET XR 50 MG-500 MG TABLET, EXTENDED RELEASE... 1 INVOKANA 100 MG TABLET... 1 INVOKANA 300 MG TABLET... 1 J JANUMET 50 MG-1,000 MG TABLET... 1 JANUMET 50 MG-500 MG TABLET... 1 JANUMET XR 100 MG-1,000 MG TABLET,EXTENDED RELEASE... 1 JANUMET XR 50 MG-1,000 MG TABLET,EXTENDED RELEASE... 1 JANUMET XR 50 MG-500 MG TABLET,EXTENDED RELEASE... 1 JANUVIA 100 MG TABLET... 1 JANUVIA 25 MG TABLET... 1 JANUVIA 50 MG TABLET... 1 JARDIANCE 10 MG TABLET... 1 JARDIANCE 25 MG TABLET... 1 JENTADUETO 2.5 MG-1,000 MG TABLET... 1 JENTADUETO 2.5 MG-500 MG TABLET... 1 JENTADUETO 2.5 MG-850 MG TABLET... 1 JENTADUETO XR 2.5 MG-1,000 MG TABLET, EXTENDED RELEASE... 1 JENTADUETO XR 5 MG-1,000 MG TABLET, EXTENDED RELEASE... 1 N NEUPOGEN 300 MCG/0.5 ML INJECTION SYRINGE... 5 NEUPOGEN 300 MCG/ML INJECTION SOLUTION... 5 NEUPOGEN 480 MCG/0.8 ML INJECTION SYRINGE... 5 NEUPOGEN 480 MCG/1.6 ML INJECTION SOLUTION... 5 NEUPRO 1 MG/24 HOUR TRANSDERMAL 24 HOUR PATCH... 8 NEUPRO 2 MG/24 HOUR TRANSDERMAL 24 HOUR PATCH... 8 NEUPRO 3 MG/24 HOUR TRANSDERMAL 24 HOUR PATCH... 8 NEUPRO 4 MG/24 HOUR TRANSDERMAL 24 HOUR PATCH... 8 NEUPRO 6 MG/24 HOUR TRANSDERMAL 24 HOUR PATCH... 8 NEUPRO 8 MG/24 HOUR TRANSDERMAL 24 HOUR PATCH... 8 NIVESTYM 300 MCG/0.5 ML SUBCUTANEOUS SYRINGE... 5 NIVESTYM 480 MCG/0.8 ML SUBCUTANEOUS SYRINGE... 5 O OZEMPIC 0.25 MG OR 0.5 MG (2 MG/1.5 ML) SUBCUTANEOUS PEN INJECTOR... 9 OZEMPIC 1 MG/DOSE (2 MG/1.5 ML) SUBCUTANEOUS PEN INJECTOR... 9 P pimecrolimus 1 % topical cream... 14 Q QTERN 10 MG-5 MG TABLET... 10 R RHOFADE 1 % TOPICAL CREAM... 11 RHOPRESSA 0.02 % EYE DROPS... 12 RYTARY 23.75 MG-95 MG CAPSULE,EXTENDED RELEASE... 13 RYTARY 36.25 MG-145 MG CAPSULE,EXTENDED RELEASE... 13 RYTARY 48.75 MG-195 MG CAPSULE,EXTENDED RELEASE... 13 RYTARY 61.25 MG-245 MG CAPSULE,EXTENDED RELEASE... 13 S SAPHRIS 10 MG SUBLINGUAL TABLET... 3 SAPHRIS 2.5 MG SUBLINGUAL TABLET... 3 SAPHRIS 5 MG SUBLINGUAL TABLET 3 21

SYNJARDY 12.5 MG-1,000 MG TABLET... 1 SYNJARDY 12.5 MG-500 MG TABLET. 1 SYNJARDY 5 MG-1,000 MG TABLET... 1 SYNJARDY 5 MG-500 MG TABLET... 1 SYNJARDY XR 10 MG-1,000 MG TABLET, EXTENDED RELEASE... 1 SYNJARDY XR 12.5 MG-1,000 MG TABLET, EXTENDED RELEASE... 1 SYNJARDY XR 25 MG-1,000 MG TABLET, EXTENDED RELEASE... 1 SYNJARDY XR 5 MG-1,000 MG TABLET, EXTENDED RELEASE... 1 T TRADJENTA 5 MG TABLET... 1 TRELEGY ELLIPTA 100 MCG-62.5 MCG-25 MCG POWDER FOR INHALATION... 15 TRESIBA FLEXTOUCH U-100 INSULIN 100 UNIT/ML (3 ML) SUBCUTANEOUS PEN... 16 TRESIBA FLEXTOUCH U-200 INSULIN 200 UNIT/ML (3 ML) SUBCUTANEOUS PEN... 16 TRESIBA U-100 INSULIN 100 UNIT/ML SUBCUTANEOUS SOLUTION... 16 TRULICITY 0.75 MG/0.5 ML SUBCUTANEOUS PEN INJECTOR... 1 TRULICITY 1.5 MG/0.5 ML SUBCUTANEOUS PEN INJECTOR... 1 U ULORIC 40 MG TABLET... 18 ULORIC 80 MG TABLET... 18 V VYZULTA 0.024 % EYE DROPS... 19 Z zileuton er 600 mg tablet,extended release 12hr mphase... 7 ZYFLO 600 MG TABLET... 7 22